Lampe, C.; Pick, M.; Knuf, M.
Pharmakologische Neuroprotektion bei FrühgeborenenKinderärztliche Praxis. Bd. 85. 2015 S. 23-26
Niesvizky, Ruben; Badros, Ashraf Z.; Costa, Luciano J. et al.
Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myelomaLEUKEMIA & LYMPHOMA. Bd. 56. H. 12. 2015 S. 3320-3328
Zuraw, B. L.; Cicardi, M.; Longhurst, H. J. et al.
Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrateALLERGY. Bd. 70. H. 10. 2015 S. 1319-1328
Wolin, Edward M.; Jarzab, Barbara; Eriksson, Barbro et al.
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analoguesDRUG DESIGN DEVELOPMENT AND THERAPY. Bd. 9. 2015 S. 5075-5086
Eberhardt, Wilfried Ernst Erich; Poettgen, Christoph; Gauler, Thomas Christoph et al.
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 35. 2015 S. 4194-+
Mai, E. K.; Bertsch, U.; Duerig, J. et al.
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myelomaLEUKEMIA. Bd. 29. H. 8. 2015 S. 1721-1729
Krebs, F.; Uenal, Oe; Hahn, S. A. et al.
Phenotypical changes of melanoma cells and T cell subsets providing a loophole for relapse in Vemurafenib therapyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 13. 2015 S. 32-32
Michal, M.; Schulz, A.; Coldewey, M. et al.
PHQ-2 and GAD-2 scores predict mortality in patients undergoing oral anticoagulationJOURNAL OF PSYCHOSOMATIC RESEARCH. Bd. 78. H. 6. 2015 S. 615-615
Spindeldreier, Kirsten C.; Thiesen, Judith; Kraemer, Irene
Physicochemical stability of cabazitaxel containing premix solution and diluted infusion solutionsEUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE. Bd. 22. H. 5. 2015 S. 260-266
Spindeldreier, K; Thiesen, j
Physicochemical stability of cabazitaxel containing premix solution and diluted infusion solutions 2015European Journal of hospital pharmacy. Bd. 22. 2015 S. 260-266